We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.52B
AUM Growth
-$2.44B
Cap. Flow
-$2.44B
Cap. Flow %
-44.19%
Top 10 Hldgs %
51.97%
Holding
165
New
38
Increased
22
Reduced
40
Closed
65

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$420M
2
TRP icon
TC Energy
TRP
+$318M
3
CF icon
CF Industries
CF
+$203M
4
BABA icon
Alibaba
BABA
+$129M
5
PXD
Pioneer Natural Resource Co.
PXD
+$129M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$504M
2
WBA
Walgreens Boots Alliance
WBA
+$478M
3
VLO icon
Valero Energy
VLO
+$244M
4
HCA icon
HCA Healthcare
HCA
+$241M
5
WMB icon
Williams Companies
WMB
+$181M

Sector Composition

Rank Sector Weight
1 Healthcare 28.63%
2 Energy 26.23%
3 Materials 9.07%
4 Consumer Discretionary 7.49%
5 Technology 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HES
76
DELISTED
Hess
HES
$4.54M 0.08%
+48,100
New +$4.76M
CEMP
77
DELISTED
Cempra, Inc.
CEMP
$4.38M 0.08%
400,000
-350,000
-47% -$3.45M
TSRO
78
DELISTED
TESARO, Inc.
TSRO
$4.04M 0.07%
+150,000
New +$4.41M
TMUS icon
79
T-Mobile US
TMUS
$195B
$3.77M 0.07%
+130,500
New +$4.02M
IPXL
80
DELISTED
Impax Laboratories, Inc.
IPXL
$3.56M 0.06%
150,000
-350,000
-70% -$8.97M
NOC icon
81
Northrop Grumman
NOC
$76B
$3.53M 0.06%
+26,800
New +$3.38M
KPTI icon
82
Karyopharm Therapeutics
KPTI
$155M
$3.49M 0.06%
6,667
-3,333
-33% -$1.88M
TSN icon
83
CALL
Tyson Foods
TSN
$21.5B
$3.46M 0.06%
+88,000
New +$3.37M
DVN icon
84
Devon Energy
DVN
$51.3B
$3.46M 0.06%
50,700
-428,400
-89% -$31.9M
SNDK
85
DELISTED
SANDISK CORP
SNDK
$2.97M 0.05%
30,300
-344,000
-92% -$33.7M
MGNX icon
86
MacroGenics
MGNX
$233M
$2.09M 0.04%
100,000
-200,000
-67% -$4.14M
AMAG
87
DELISTED
AMAG Pharmaceuticals
AMAG
$1.92M 0.03%
+60,000
New +$1.28M
AFMD
88
DELISTED
Affimed
AFMD
$1.89M 0.03%
+30,000
New +$1.87M
CMRX
89
DELISTED
Chimerix, Inc.
CMRX
$1.38M 0.03%
+50,000
New +$1.21M
LVNTA
90
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$1.23M 0.02%
32,400
-20,103
-38% -$736K
LEA icon
91
Lear
LEA
$7.39B
$847K 0.02%
9,800
+800
+9% +$77.3K
HDS
92
DELISTED
HD Supply Holdings, Inc.
HDS
$842K 0.02%
+30,900
New +$844K
PAGP icon
93
Plains GP Holdings
PAGP
$5.28B
$766K 0.01%
9,388
-62,786
-87% -$5.1M
KITE
94
DELISTED
Kite Pharma, Inc.
KITE
$713K 0.01%
+25,000
New +$619K
GOOG icon
95
Alphabet (Google) Class C
GOOG
$4.11T
$647K 0.01%
22,060
-94,258
-81% -$2.73M
CAR icon
96
Avis
CAR
$5.47B
$593K 0.01%
10,800
-10,500
-49% -$656K
JAH
97
DELISTED
JARDEN CORPORATION
JAH
$570K 0.01%
14,229
-205,500
-94% -$8.04M
HRI icon
98
Herc Holdings
HRI
$4.78B
$449K 0.01%
5,900
-51,767
-90% -$4.42M
WHR icon
99
Whirlpool
WHR
$2.49B
$422K 0.01%
+2,900
New +$429K
PAM icon
100
Pampa Energía
PAM
$4.57B
$202K ﹤0.01%
+18,800
New +$189K
2 3
4
5 6

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q3 2014 Portfolio in Review

As of Q3 2014, PointState Capital held 165 positions worth $5.52B, down 31% from $7.96B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

PointState Capital withdrew a net $2.44B in Q3 2014, closing 65 positions and reducing 40 holdings. Its most notable exit was Paramount Global Class B, an estimated $504M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Energy and Materials.

Against the trend, PointState Capital opened a new position in AbbVie worth $437M.

  • PointState Capital's largest Q3 2014 buy was AbbVie: 7,568,600 shares worth $437M.
  • PointState Capital added most to CF Industries in Q3 2014, an estimated $203M increase.
  • PointState Capital's biggest Q3 2014 reduction was Walgreens Boots Alliance, cutting an estimated $478M.
  • PointState Capital fully exited Paramount Global Class B in Q3 2014, selling an estimated $504M.
  • PointState Capital's ten largest holdings make up 52% of its $5.52B portfolio in Q3 2014.
  • PointState Capital opened 38 new positions and closed 65 in Q3 2014.
  • PointState Capital's portfolio value fell 31% quarter-over-quarter to $5.52B.

Based on PointState Capital's 13F filing for Q3 2014, filed 14 Nov 2014.